Bristol Myers second-quarter results beat expectations, helped by new drugs
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia…
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia…
MEXICO CITY (Reuters) -Alleged Mexican kingpin Ismael “El Mayo” Zambada has pleaded not guilty to U.S. drug trafficking charges, court…
By Allison Lampert and David Shepardson WASHINGTON (Reuters) -Boeing is asking suppliers to disclose records on Chinese titanium since 2014,…
By Sheila Dang (Reuters) – The Paris Olympics will be a showcase of generative AI for American viewers but European…